期刊文献+

融合C3Fab抗PD-L1纳米抗体的制备及其对血浆半衰期的影响

Preparation of anti-PD-L1 nanobodies fused with C3Fab and their effect on plasma half-life
原文传递
导出
摘要 目的制备融合C3Fab的抗程序性死亡-配体1(PD-L1)纳米抗体P3C8-C3Fab,并研究其对血浆半衰期的影响。方法将来源于蛋白G的C3Fab肽段,通过DNA重组技术与纳米抗体P3C8进行分子融合,并构建重组质粒pET21a-P3C8-C3Fab,在大肠杆菌BL21菌株中进行诱导表达和纯化,并采用酶联免疫吸附试验(ELISA)检测P3C8-C3Fab与PD-L1蛋白、小鼠IgG和表达PD-L1肿瘤细胞的结合,利用双抗夹心ELISA检测不同时间小鼠血清中残留P3C8-C3Fab,以评估C3Fab对PD-L1纳米抗体血浆半衰期的延长作用。结果成功构建了融合C3Fab的抗PD-L1纳米抗体P3C8-C3Fab,其在BL21菌中以可溶形式高效表达,经纯化获得质量分数约为90%的NbP3C8-C3Fab蛋白,得率为7.18 mg/L。P3C8-C3Fab随着质量浓度的增加,对PD-L1蛋白和小鼠IgG亲和力也逐渐升高,且呈现浓度相关性;P3C8-C3Fab与肺癌A549细胞的结合呈浓度相关性。小鼠血清中P3C8-C3Fab的浓度标准曲线呈典型的S型浓度相关性;P3C8血浆半衰期仅为0.44 h,而P3C8-C3Fab的血浆半衰期达到9.36 h,血浆半衰期延长了21.27倍。结论C3Fab与纳米抗体P3C8连接可以显著延长其血浆半衰期,对改善纳米抗体的体内作用具有应用价值。 Objective To prepare the anti-programmed death-ligand 1(PD-L1)nanoantibody P3C8-C3Fab by ligating with C3Fab and to investigate its role in plasma half-life.Methods The C3Fab peptide derived from protein G was molecularly fused with the nanobody P3C8 by DNA recombination technology.The nanoantibody P3C8-C3Fab was inducibly expressed and purified in the E.coli BL21 strain,and the binding of it to PD-L1 protein,mouse IgG,and PD-L1-expressing tumor cells was detected by enzyme-linked immunosorbent assay(ELISA).The residual P3C8-C3Fab was detected in mouse serum at different times using double-antibody sandwich ELISA to assess the prolongation of the plasma half-life of PD-L1 nanobodies by C3Fab.Results The nanoantibody P3C8-C3Fab was successfully constructed,and it could efficiently express itself in soluble form in BL21.The purified NbP3C8-C3Fab protein was obtained with a mass fraction of about 90%at a yield of 7.18 mg/L.The affinity of P3C8-C3Fab for PD-L1 protein and mouse IgG gradually increased with increasing mass concentration and showed a concentration correlation.The binding of P3C8-C3Fab to lung cancer A549 cells showed a concentration correlation.The concentration standard curve of P3C8-C3Fab in mouse serum showed a typical S-shape with a concentration correlation.The plasma half-life of P3C8 was only 0.44 h,while the plasma half-life of P3C8-C3Fab was 21.27-fold higher,up to 9.36 h.Conclusions The linkage of C3Fab to the nanobodies of P3C8 can significantly prolong the plasma half-life of P3C8,which is valuable for the improvement of in vivo nanobody effects.
作者 王展雄 雷萌 邓奕辰 娄楚 杨天宁 胡倩倩 李江伟 Lei Meng;Deng Yichen;Lou Chu;Yang Tianning;Hu Qianqian;Li Jiangwei(College of Life Science and Technology,Xinjiang University,Urumqi 830046,China)
出处 《国际生物医学工程杂志》 CAS 2024年第1期53-59,共7页 International Journal of Biomedical Engineering
基金 国家自然科学基金(31570935) 新疆大学自治区级大学生创新训练计划(S202210755077)。
关键词 程序性死亡受体-1 纳米抗体 半衰期 IgG结合肽C3Fab Programmed death receptor-1 Nanobody Half-life IgG binding peptide C3Fab
  • 相关文献

参考文献9

二级参考文献49

  • 1廖建民,张奉国,常高翔,沈子龙.^(125)I示踪法研究rhPTH_(1~34)在大鼠体内的药代动力学[J].同位素,2006,19(4):223-227. 被引量:3
  • 2刘庆平,苏秀兰,闫美荣,陈春华,舍英,沈秀清.抗胃癌生物活性肽对荷胃癌裸鼠酯酶同工酶代谢的影响[J].中国肿瘤生物治疗杂志,1997,4(1):61-63. 被引量:7
  • 3Garaci E, Pica F, Sinibaldi-Vallebona P, et al. Thymosin alpha(1)in combination with cytokines and chemotherapy for the treatment of cancer [J]. Int Immunopharmacol, 2003, Aug;3(8): 1 145.
  • 4Filippov AK, Kozlov SA, Pluzhnikov KA et al. M-type K+ current inhibition by a toxin fron the scorpion Buthus eupeus [J]. FEBS Lett, 1996, 384(3):277.
  • 5Trikaha M, clerck YAD, Markland FS. Controtrostain ,a snake venom disintegrin , inhibits β1 integrinmediated human metastatic melanoma cell adhesin and blocks experimental metastasis [J].Cancer Res, 1994, 54(18): 4 993.
  • 6Fujisawa N, Sakao Y, Hayashi S. Alpha-Chemokine growth factor for adenocarcinomas, a synthetic peptide inhibitor for alphachemokines inhibits the growth of adenocarcinoma cell lines [J]. J Cancer Res Clin Oncol, 2000, 126(1):19.
  • 7Pawlikowski M, Melen-Mucha G. Perspectives of new potential therapeutic applications of somatostatin analogs [J]. Neuroendocrinol Lett, 2003,24(1-2): 21.
  • 8Issaeva N, Friedler A, Bozko P, et al. Rescue of mutants of the tumor suppressor p53 in cancer cells by a designed peptide [J]. Proc Natl Acad Sci U S A, 2003,100(23):13 303.
  • 9Chene P, Fuchs J, Bohn J. A small synthetic peptide, which inhibits the p53-hdm2 interaction, stimulates the p53 pathway in tumour cell lines [J]. J Mol Biol, 2000, 299(1): 245.
  • 10Warren P, Li LJ, Song W, et al. Vitro Targeted Killing of Prostate Tumor Cells by a Synthetic Amoebapore Helix 3 Peptide Modified with Two r-linked Glutamate Residues at the COOH Terminus [J].Cancer Res, 2001, 61:6 783.

共引文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部